Goldman Sachs:
- Reiterated Outperform on DNA, COF and GCI.
- Reiterated Underperform on PBG.
Smith Barney:
- Reiterated Buy on DNA, target $87.50.
- Reiterated Sell on IMCL, target $36.
- Reiterated Buy on CELG, target $41.
- Reiterated Buy on LRCX, target $38.
Morgan Stanley:
- Raised TLWT to Overweight, target $23.
JP Morgan:
- Cut WDC to Underweight.
- Rated GBBK Underweight.
- Raised SHW to Overweight.
- Rated PCBC Overweight.
Banc of America:
- Rated ALB Buy, target $41.
CSFB:
- Downgraded SKS to Underperform, target $14.
CIBC:
- Raised NICE to Sector Outperform, target $46.
Legg Mason:
- Rated WYNN Buy, target $80.
Merrill Lynch:
- Raised CUNO to Buy, target $60.
- Raised CSCO to Buy and added to Focus 1 stock list.
UBS:
- Rated URS Buy, target $45.
- Rated MHS Buy, target $67.
- Raised UGI to Buy, target $56.
- Reiterated Buy on OTEX, target $22.
- Reiterated Reduce on BMC, target $14.
Bear Stearns:
- Reiterated Outperform on HET, target $83.
Prudential:
- Reiterated Overweight on PD, target $137.
No comments:
Post a Comment